CooperCompanies, US2166485019

CooperCompanies stock sits 17.23 percent below Stifel's USD 70.00 target

Published on 10/17/2026 at 22:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Market value stood at USD 11.0 billion on October 16, 2026. CooperCompanies stock costs USD 57.94 on October 16, 2026, up 0.94 percent versus the prior close.

Analyst target and valuation

  • Stifel maintained a USD 70.00 target for CooperCompanies on October 1, 2026.
  • CooperCompanies had a USD 11.0 billion market value on October 16, 2026.
  • CooperCompanies stock closed at USD 57.94 on Nasdaq on October 16, 2026 at 4:00 p.m. ET, up 0.94 percent from the prior close.
  • Its price-to-earnings ratio was 19.77 on October 16, 2026.
CooperCompanies Reinraum-Produktion US21664P1039 zeigt automatisierte Kontaktlinsen-Fertigungslinien mit optischer Qualitätsprüfung im sterilen Reinraumbereich, Illustration mit AI erstellt.

Stifel maintained its Buy rating and a USD 70.00 price target for CooperCompanies on October 1, 2026, according to Investing.com. The target stood 17.23 percent above the Nasdaq closing price of USD 57.94 on October 16, 2026. CooperCompanies stock closed up 0.94 percent from the prior close at 4:00 p.m. ET.

Market value reaches USD 11.0 billion

The medical device company had a market capitalization of USD 11.0 billion on October 16, 2026. Its fiscal third-quarter revenue was USD 1.07 billion for the period ended July 31, 2026, while net income attributable to common shareholders was USD 432.8 million.

Price sits within a wide range

CooperCompanies stock traded between USD 51.01 and USD 89.83 over the 52 weeks through October 16, 2026. The closing price was 35.51 percent below the 52-week high and 13.59 percent above the 52-week low. Trading volume reached 3,773,307 shares against an average of 3,313,807 shares.

Valuation and earnings quality

The price-to-earnings ratio was 19.77 on October 16, 2026, while the dividend yield was 0.00 percent. The third-quarter net profit margin was 40.59 percent, and operating cash flow for the period reached USD 341.7 million. Investing.com reported that fiscal third-quarter revenue missed expectations and that management lowered fiscal 2026 guidance, with adjusted earnings per share meeting expectations after tariff refunds.

Comparison with peers

CooperCompanies (Nasdaq, USD): plus 0.94 percent, P/E 19.77, market capitalization USD 11.0 billion
Alcon (NYSE, USD): minus 0.60 percent, P/E 50.91, market capitalization USD 32.0 billion
DENTSPLY SIRONA (Nasdaq, USD): minus 2.94 percent, P/E minus 3.13, market capitalization USD 1.7 billion

Analyst target leaves room for debate

Stifel's USD 70.00 target provides a clear valuation reference, but its rating remains tied to company-specific execution and fiscal 2026 guidance. The 52-week range also shows that the October 16 close remained materially below the recent high.

The closing price was USD 57.94 on Nasdaq on October 16, 2026 at 4:00 p.m. ET, up 0.94 percent from the prior close. The further course of trading is shown by the continuously updated real-time quote of CooperCompanies stock.

CooperCompanies stock at a glance

  • Company: The Cooper Companies, Inc.
  • ISIN: US2166485019
  • Ticker: COO
  • Primary exchange: Nasdaq
  • Price Nasdaq as of October 16, 2026, 4:00 p.m. ET: USD 57.94
  • Change versus prior close: plus 0.94 percent
  • Market capitalization: USD 11.0 billion (as of October 16, 2026)
  • 52-week range: USD 51.01-89.83 (as of October 16, 2026)
  • Sector / Industry: Health care / Medical devices
  • Index membership: S&P 500

Market context: Market report S&P 500.

More news and analyses on CooperCompanies stock

Disclaimer...
en | US2166485019 | COOPERCOMPANIES | boerse | 70351467 | bgmi